A Placebo-Controlled Trial of Bupropion Combined with Nicotine Patch for Smoking Cessation in Schizophrenia
- 21 December 2007
- journal article
- research article
- Published by Elsevier in Biological Psychiatry
- Vol. 63 (11) , 1092-1096
- https://doi.org/10.1016/j.biopsych.2007.11.002
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- A 12-Week Double-Blind, Placebo-Controlled Study of Bupropion SR Added to High-Dose Dual Nicotine Replacement Therapy for Smoking Cessation or Reduction in SchizophreniaJournal of Clinical Psychopharmacology, 2007
- A double-blind placebo-controlled cross over trial of bupropion in smoking reduction in schizophreniaSchizophrenia Research, 2005
- A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviorsSchizophrenia Research, 2005
- Co‐Morbidity of Smoking in Patients with Psychiatric and Substance Use DisordersThe American Journal on Addictions, 2005
- Management of smoking in people with psychiatric disordersCurrent Opinion in Psychiatry, 2003
- Biochemical verification of tobacco use and cessationNicotine & Tobacco Research, 2002
- A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophreniaNicotine & Tobacco Research, 2001
- Nicotine Transdermal Patch and Atypical Antipsychotic Medications for Smoking Cessation in SchizophreniaAmerican Journal of Psychiatry, 2000
- Use of random-sequence riboflavin as a marker of medication compliance in chronic schizophrenicsSchizophrenia Research, 1991
- The Contemplation Ladder: Validation of a measure of readiness to consider smoking cessation.Health Psychology, 1991